CJC-1295 no DAC / Ipamorelin

Overview

CJC-1295 no DAC / Ipamorelin is a short-pulse GH-axis stack. It combines a short-acting GHRH-side analog with Ipamorelin's ghrelin/GHS-receptor signal to organize discrete GH-release windows. [1][2][5][6]

The practical reason for the stack is timing control: both components can be placed around short GH-pulse windows instead of sustained exposure. That timing logic does not establish the stack for recovery, fat loss, sleep, or longevity outcomes. [2][8]

Peptides in this stack

Why They're Combined

CJC-1295 no DAC is included for short GHRH-side pituitary signaling, while Ipamorelin is included for ghrelin/GHS-receptor stimulation. The combination is common because each compound pushes GH release through a different upstream route. [1][2][5][6]

No-DAC timing is the point. The stack is used to create short, repeatable release windows rather than long background stimulation. That makes timing, meals, sleep, and training context part of the protocol logic. [2][3]

How They Work Together

The proposed mechanism is a coordinated pulse: a GHRH-side signal primes pituitary GH release while Ipamorelin activates the secretagogue receptor side. Pairing them is meant to create a more organized pulse than either signal alone. [1][2][6]

Because the stack still feeds the GH/IGF-1 axis, the downstream monitoring issues stay in the same family: IGF-1, glucose, edema, numbness or tingling, sleep quality, and anti-doping status. Shorter action does not remove those considerations. [8][9][10]

What the Evidence Shows

The no-DAC rationale leans on human GHRH(1-29) and D-Ala2 GHRH pharmacology plus Ipamorelin component data. Those sources support receptor and timing logic more than real-world outcome claims. [1][2][6]

No controlled human trial establishes that no-DAC CJC-1295 plus Ipamorelin improves sleep, recovery, fat loss, lean mass, or aging outcomes. Treat the stack as pulse logic with incomplete outcome evidence, not a proven recovery or body-composition protocol. [8][7]

Typical Protocol

Common no-DAC stack pulses use Modified GRF 1-29 at 100-200 mcg with Ipamorelin at 200-300 mcg per administration. Bedtime is the most common anchor, with some schedules adding a morning or post-workout pulse away from heavy meals. [2][6][8]

Common cycle structures are daily dosing or 5-days-on, 2-days-off for 8-12 weeks before symptoms and labs are reviewed. The main practical rule is consistency: changing dose, timing, meals, and training in the same week makes the stack hard to read. [8][7]

Important Considerations

This stack is often confused with CJC-1295 DAC / Ipamorelin. Keep them separate: no-DAC is pulse-oriented, while DAC is longer acting and carries different exposure assumptions. Food timing, pulse spacing, and missed doses matter more with the no-DAC version. [2][3][4]

Product quality and dose precision matter because small microgram mistakes can change the effective pulse. IGF-1, fasting glucose, edema, numbness or tingling, sleep quality, and blood pressure are practical review points. Tested athletes should treat GHRH analogs and GH secretagogue stacks as anti-doping risk areas. [9][10][8]

Published research 10 sources